Drugs / acetylsalicylic acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05122455 | Sep 2021 → Jun 2024 | — | University of Sao Paulo | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2012-08-26 | Daiichi Sankyo | Results Daiichi Sankyo and Lilly Announce TRILOGY ACS Results Regarding Effient(R) (Prasugrel) in Acute Coronary Syndrome UA/NSTEMI Patients to be Managed Medically without an Artery-Opening Procedure daiichisankyo.com ↗
This outcome was not statistically significant (P=0.21). |
All press releases naming this drug 1 release
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | acetylsalicylic acid | “low-dose acetylsalicylic acid (ASA)” NCT05122455 ↗ |
| Known as | ASA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05122455 ↗ |